JASON CHEYNEY: Open Payments
NPI 1942207840 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$486 in 41 payments from 7 companies in 2025. Trend: 2023 $388 · 2024 $444 · 2025 $486
Food & beverage: $486
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $191 |
| Galderma Laboratories, L.P. | 7 | $121 |
| Novartis Pharmaceuticals Corporation | 3 | $54 |
| GENZYME CORPORATION | 3 | $49 |
| PFIZER INC. | 2 | $37 |
| Janssen Biotech, Inc. | 1 | $20 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
Products named: RINVOQ, NEMLUVIO, DUPIXENT, CIBINQO, COSENTYX, SKYRIZI, TREMFYA.
Industry payments across GA — which companies pay providers there.
